
Sign up to save your podcasts
Or


This episode brings together four conversations on the topic of GLP-1 the science, the market data, the human impact, and the long-term strategic picture.
We hear from scientists, market strategists, clinicians and food innovators on what GLP-1 actually means for the food industry, and what it means for the people eating differently because of it.
Some market data suggests households on GLP-1 medications are spending 6% less on food overall. The consumer segment using these drugs in the UK is already roughly the same size as the vegan and vegetarian market.
How the food industry responds to this disruptive influence remains an open question, although serious moves are already being made.
By Food Matters Live4.2
55 ratings
This episode brings together four conversations on the topic of GLP-1 the science, the market data, the human impact, and the long-term strategic picture.
We hear from scientists, market strategists, clinicians and food innovators on what GLP-1 actually means for the food industry, and what it means for the people eating differently because of it.
Some market data suggests households on GLP-1 medications are spending 6% less on food overall. The consumer segment using these drugs in the UK is already roughly the same size as the vegan and vegetarian market.
How the food industry responds to this disruptive influence remains an open question, although serious moves are already being made.

396 Listeners

52 Listeners

480 Listeners

259 Listeners

346 Listeners

245 Listeners

745 Listeners

3,903 Listeners

143 Listeners

277 Listeners

266 Listeners

46 Listeners

2,131 Listeners

1,314 Listeners

907 Listeners